Alzheimer's, Dementia Rate To Double In US by 2060

Faith Castro
September 24, 2018

In fact, scientists have found pieces of evidence of a protein found in Alzheimer's disease, called amyloid, in the brains of people as young as 20.

As the United States of America's aging population keeps growing, so does the people with Alzheimer's disease and related dementias.

However, the disease is not an immediate decline and people can live normal lives for years after their diagnosis, experts say.

In the United States, more than 5 million Americans are living with Alzheimer's disease, the sixth-leading cause of death in America and the only disease among the top ten causes that can not be cured, prevented or even slowed. The most common form of dementia, Alzheimer's disease causes the decline of cognitive function, which can leave sufferers unable to carry out daily tasks and activities. "Early identification of Alzheimer's disease is crucial for better management", said Dr Sunil Suthar, geriatric psychiatrist, department of psychiatry, SMS medical college.

The Alzheimer's Association Walk to End Alzheimer'sis the world's largest event to raise awareness and funds for Alzheimer's care, support and research.

'Many people actually put off getting a diagnosis because they are anxious about having to immediately give up work or stop driving.

More news: JOAQUIN PHOENIX in JOKER Makeup

Behaviour-A person with Alzheimer's may behave out-of-character.

The numbers are expected to triple by 2050 to 152 million, according to the World Health Organisation, posing a huge challenge to health care systems. However, the diagnosis of younger onset dementia can prove hard.

Sawai Man Singh Medical College to have a separate dementia clinic for treatment of Alzheimer's disease at its psychiatric centre in Adarsh Nagar which will be operational from Monday. However, there are medications that can help reduce the symptoms to slow down the worsening of the disease.

Fact: As of now there is no treatment to cure, delay or stop the progression of Alzheimer's disease. It has been one year since the adoption of the World Health Organisation's (WHO) landmark Global Plan of Action on the Public Health Response to Dementia 2017-2025, but now more than ever we need strong global advocacy to ensure that governments implement and fund national dementia plans. Alzheimer's Research UK shares that belief.

Another obstacle is people's aversion to finding out whether they are at risk for developing Alzheimer's, Porsteinsson said.

Other reports by LeisureTravelAid

Discuss This Article